China is conducting clinical trials of 16 COVID-19 vaccines, seven of which have entered phase III trials and one has conditionally hit the market, said Wu Yuanbin, an official with the Ministry of Science and Technology, at a hematology conference on Saturday.
Packs of inactivated COVID-19 vaccine are seen at a packaging plant of Beijing Biological Products Institute Co., Ltd., Beijing, China, December 25, 2020. /Xinhua
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3